Krystal Biotech Q3 revenue improves 30% to $127.3m
Krystal Biotech (NASDAQ:KRYS) reported third-quarter 2026 VYJUVEK net revenue of $127.3 million, up 30% year over year, while maintaining a gross margin of 94%.
Krystal Biotech (NASDAQ:KRYS) reported third-quarter 2026 VYJUVEK net revenue of $127.3 million, up 30% year over year, while maintaining a gross margin of 94%.
TAT Technologies (NASDAQ:TATT) reported third-quarter 2026 revenue of $55.6 million, up 20.2% year over year, as stronger business activity supported higher profitability and earnings.
Public Service Enterprise Group (NYSE:PEG) reported third-quarter 2026 net income of $376 million, as diluted earnings per share declined to $0.76 from $1.24 in the previous year's quarter.
Lumentum Holdings (NASDAQ:LITE) reported fiscal first-quarter 2027 revenue of $1.26 billion, with GAAP net income of $360.3 million, as demand for optical technologies used in AI data centres supported business growth.
Tempus AI (NASDAQ:TEM) reported third-quarter 2026 revenue of $411.5 million, up 23% year over year, exceeding analyst expectations and prompting higher full-year revenue guidance.
NAPCO Security Technologies (NASDAQ:NSSC) reported fiscal first-quarter 2027 revenue of $50 million, up 1.7% year over year, while net income increased 6.9% to $13 million.
Marriott International (NASDAQ:MAR) reported third-quarter 2026 net income of $794 million, up 9% year over year, as stronger hotel room revenue supported earnings growth and improved its full-year outlook.
Information Services Group (NASDAQ:III) reported third-quarter 2026 revenue of $65.1 million, up 4.4% year over year, exceeding its guidance as profitability and operating cash flow increased.
IDEXX Laboratories (NASDAQ:IDXX) reported third-quarter 2026 revenue of $1.214 billion, up 10% year over year, as stronger veterinary diagnostics demand supported earnings growth and higher full-year financial forecasts.
Entergy (NYSE:ETR) reported third-quarter 2026 earnings of $940 million, up from $694 million a year earlier, while earnings per share increased to $1.98 from $1.53.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy